As a Senior Vice President, Michael designs and oversees commercial strategy assignments in both the Health & Life Sciences and Financial Services practices at NAXION. Michael is a neuropsychologist by training whose methodological skill set give him exceptional breadth and flexibility in the techniques he uses and the marketing yield he can extract from research. A skilled qualitative moderator who has conducted thousands of in-depth interviews with physicians and consumers, Michael is equally adept at designing and analyzing complex, large-scale quantitative surveys.
Assignments typically support new product development by gauging size and scope of market opportunities and ways to optimize commercialization strategies, from development through, lifecycle management. Many of his projects help clients chart a "new" opportunity or reconceive a market landscape undergoing change in response to new technologies and evolving standards of care. In those settings, his role has been to devise segmentation strategy and clarify drivers of adoption and usage as well as help to set pricing strategies. In the healthcare arena, he has particular expertise in several therapeutic categories including neurological and psychiatric disorders, pain and inflammation, cardiovascular disease, metabolic disease and respiratory conditions.
Michael also provides intellectual leadership on a diverse set of topics ranging from neuromarketing to health economics and regulatory compliance. His articles have appeared in peer-reviewed publications like the Journal of Medical Economics and Marketing Bulletin, as well as business publications like The Financial Times.
Prior to joining NAXION, Michael was a Professor of Neuropsychology at Victoria University in Wellington, New Zealand. His extensive portfolio of academic research has focused on several aspects of human neuropsychology, including the effects of pharmacological agents on memory and the effects of stroke on language and attention. Michael's neuro-psychology research has been published in refereed medical, psychology, and general science journals.
Michael earned a Ph.D. in Experimental Psychology from Cambridge University after completing a B.A. with Honors in Psychology at Emory University.